A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

* Age less than 21 years at diagnosis * Previously untreated, pathologically confirmed diagnosis of Hodgkin's disease. * Informed patient/parental consent as required by individual institution and in accordance with the Dept of Health and Human Services * Approval of this protocol by the individual institutional Human Subjects Review Committee. * Indicate Hodgkin's disease clinical stage. * Indicate presence or absence of "B" symptoms. * For Stage I and II disease indicate the following: * presence or absence of bulk disease * number of involved nodal regions * presence or absence of hilar adenopathy